US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

667.48

-7.8452-1.16%

Number of Gainers:59

Number of Losers:84

Number of Flat:10

PE:- -

High:674.97

Open:674.97

Low:658.46

Close:675.33

Volume:347.22M

Turnover:7.94B

Market Cap:461.48B

Float Cap:354.60B

Loading ...

SentinelOne CEO Tomer Weingarten Disposes of 527,368 Shares Worth $13.32 Million

Stocks to Watch: Constellation, Caribou, Penguin

Mobix Labs Targets Expansion into US Rare Earth, Critical Minerals Markets Via NSM Platform

Press Release: Mobix Labs to Host Investor Update Call on Critical Minerals Strategy and Business Outlook

Nuo Therapeutics Secures Second Loan Funding with Warrants

Caribou Falls After Scrapping Cell Therapy Programs, Launches Strategic Review

Caribou Biosciences to End Drug Development, Cut Staff Due to Funding Problems

Caribou Biosciences Shares Fall 38% to $0.70 After the Bell; Announced Discontinuing CAR-T Cell Therapy Programs, Evaluating Strategic Alternatives, Substantial Job Cuts

THOMSON REUTERS

Caribou Biosciences announces restructuring, explores strategic alternatives

USCB Financial Sets Third-Quarter Results Release, Schedules Earnings Call

Caribou Biosciences - Expects $10 Mln-$11 Mln in Severance, $5 Mln-$8 Mln for Clinical Trial Wind-Down - SEC Filing

THOMSON REUTERS

Zeta Global Agrees to Acquire Digital Audience

Caribou Biosciences Plans Major Workforce Reduction, Halts CAR-T Programs

1stDibs CEO Rosenblatt, CFO Etergino to Present at LD Micro Main Event Conference

Zeta Global to Acquire Digital Audience, Extending the Zeta Data Cloud Across the Digital Ecosystem

THOMSON REUTERS

Caribou Biosciences to Evaluate Strategic Alternatives

THOMSON REUTERS

Caribou Biosciences - Reports Cash and Securities of $113.80 Mln as of June 30, 2026

THOMSON REUTERS

Caribou Biosciences - Plans Substantial Workforce Reduction Expected to be Mostly Complete in Q4 2026

THOMSON REUTERS

Caribou Biosciences - to Discontinue Vispa-Cel and CB-011 CAR-T Cell Therapy Programs

THOMSON REUTERS

Caribou Biosciences - to Implement Workforce and Cost Reductions

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BK4539/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":667.4812,"timestamp":1791403199999,"preClose":675.3264,"halted":0,"volume":347223610,"delay":0,"changeRate":-0.011617,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-7.845215,"latestTime":"10-07 16:00:00 EDT","open":674.9678,"high":674.9678,"low":658.45575,"amount":7944784778.491885,"amplitude":0.02445,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791446400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.235408,"peRate":115.607072,"turnoverRate":0.027238,"increases":59,"decrements":84,"flats":7,"marketCap":461479138064.875,"floatMarketCap":354597310553.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":674.9678,"amplitude":0.02445,"preClose":675.3264,"low":658.45575,"pbRate":"5.235408","latestPrice":667.4812,"volume":347223610,"delay":0,"open":674.9678,"prevYearClose":881.5255,"prevWeekClose":665.7447,"prevMonthClose":677.2829,"prevQuarterClose":677.2829,"fiveDayClose":677.2829,"twentyDayClose":690.0618,"sixtyDayClose":748.1126,"secType":"PLATE","market":"US","turnoverRate":0.027238,"peRate":115.607072,"marketCap":461479138064.875,"floatMarketCap":354597310553.875,"timestamp":1791403199999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":59,"down":84,"flat":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673069557","title":"SentinelOne CEO Tomer Weingarten Disposes of 527,368 Shares Worth $13.32 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2673069557","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673069557?lang=en_us&edition=fundamental","pubTime":"2026-10-07 07:08","pubTimestamp":1791328089,"startTime":"0","endTime":"0","summary":"SentinelOne CEO Tomer Weingarten disposes of 527,368 shares worth $13.32 millionSentinelOne President, CEO, Director Tomer Weingarten sold 527,368 Class A shares on Oct. 5, 2026 at USD 25.2642.He conv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL3sp06w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"SentinelOne CEO Tomer Weingarten Disposes of 527,368 Shares Worth $13.32 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4561","S","BK4585","BK4097","BK4560","LU2286300806.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673069552","title":"Stocks to Watch: Constellation, Caribou, Penguin","url":"https://stock-news.laohu8.com/highlight/detail?id=2673069552","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673069552?lang=en_us&edition=fundamental","pubTime":"2026-10-07 07:04","pubTimestamp":1791327840,"startTime":"0","endTime":"0","summary":"Constellation Brands announced the acquisition of SpikedAde. Shares declined 4.5% to $115.67 in after-hours trading Tuesday.Caribou Biosciences said it was halting development on some products, cutting staff and initiating a strategic alternatives review after running into funding problems. The stock shed 34% to 75 cents after the bell.Penguin Solutions logged higher profit in the latest quarter driven by AI demand. Shares rose 6% to $68 in late trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2552382132.HKD","IE00B66KJ199.SGD","STZ","LU2552382058.USD","OPTZ","BK4504","HBMX","BK4585","BK4141","IE00B19Z4B17.USD","CRBU","BK4539","LU2552382215.SGD","IE0031619046.USD","BK4559","PENG","BK4139","PENU","IE00B7SZL793.SGD","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673669030","title":"Mobix Labs Targets Expansion into US Rare Earth, Critical Minerals Markets Via NSM Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2673669030","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673669030?lang=en_us&edition=fundamental","pubTime":"2026-10-07 06:03","pubTimestamp":1791324199,"startTime":"0","endTime":"0","summary":"Mobix Labs targets expansion into US rare earth, critical minerals markets via NSM platformMobix Labs set an Oct. 8, 2026 investor call to outline plans to expand into U.S. rare earths and critical mi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL4sFwBz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4141","BK4539","MOBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673181066","title":"Press Release: Mobix Labs to Host Investor Update Call on Critical Minerals Strategy and Business Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2673181066","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673181066?lang=en_us&edition=fundamental","pubTime":"2026-10-07 06:03","pubTimestamp":1791324180,"startTime":"0","endTime":"0","summary":"--  Replay: Available on the Mobix Labs Investor Relations website for 12","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REMX","BK4539","BK4109","MOBX","BK4141","MTX","SPD","WEPN","MVPS","FXZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673706503","title":"Nuo Therapeutics Secures Second Loan Funding with Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2673706503","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673706503?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:18","pubTimestamp":1791321514,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Nuo Therapeutics ( ($AURX) ). On October 6, 2026, Nuo Therapeutics, Inc. completed the second funding under its...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nuo-therapeutics-secures-second-loan-funding-with-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nuo-therapeutics-secures-second-loan-funding-with-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673306593","title":"Caribou Falls After Scrapping Cell Therapy Programs, Launches Strategic Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2673306593","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673306593?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:52","pubTimestamp":1791319934,"startTime":"0","endTime":"0","summary":"BUZZ-Caribou falls after scrapping cell therapy programs, launches strategic review** Shares of biotech firm Caribou BiosciencesCRBU.Ofall 36.1% to $0.73 in extended trading** Co says it is exploring ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL4N45S1FS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673525065","title":"Caribou Biosciences to End Drug Development, Cut Staff Due to Funding Problems","url":"https://stock-news.laohu8.com/highlight/detail?id=2673525065","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673525065?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:37","pubTimestamp":1791319020,"startTime":"0","endTime":"0","summary":"Caribou Biosciences is exploring strategic alternatives and cutting jobs after it decided to discontinue the development of two of its cancer products.The biopharmaceutical company said Tuesday it wou","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRBU","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673006586","title":"Caribou Biosciences Shares Fall 38% to $0.70 After the Bell; Announced Discontinuing CAR-T Cell Therapy Programs, Evaluating Strategic Alternatives, Substantial Job Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=2673006586","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673006586?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:34","pubTimestamp":1791318841,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL6N45S19Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CRBU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673606553","title":"Caribou Biosciences announces restructuring, explores strategic alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2673606553","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673606553?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:33","pubTimestamp":1791318785,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Caribou Biosciences ( ($CRBU) ). On October 2, 2026, Caribou Biosciences’ board approved a broad restructuring ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/caribou-biosciences-announces-restructuring-explores-strategic-alternatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/caribou-biosciences-announces-restructuring-explores-strategic-alternatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673063059","title":"USCB Financial Sets Third-Quarter Results Release, Schedules Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2673063059","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673063059?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:30","pubTimestamp":1791318657,"startTime":"0","endTime":"0","summary":"USCB Financial sets third-quarter results release, schedules earnings callUSCB Financial Holdings will release Q3 2026 results for the period ended Sept. 30 on Oct. 22, 2026.Management will host an ea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDLbRmrkh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USCB","SG9999014005.SGD","LU2095319765.USD","SG9999014021.USD","BCDF","IE00BGHQF748.EUR","NDAQ","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","BK4588","LU0314104364.USD","BK4585","IE00BKPKM429.USD","BK4211","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014039.USD","BK4539","IE00BQXX3C00.GBP","BK4112","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673639130","title":"Caribou Biosciences - Expects $10 Mln-$11 Mln in Severance, $5 Mln-$8 Mln for Clinical Trial Wind-Down - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673639130","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673639130?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:09","pubTimestamp":1791317396,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nFWN45S14Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRBU","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673306395","title":"Zeta Global Agrees to Acquire Digital Audience","url":"https://stock-news.laohu8.com/highlight/detail?id=2673306395","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673306395?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:07","pubTimestamp":1791317225,"startTime":"0","endTime":"0","summary":"Zeta Global agrees to acquire Digital AudienceZeta Global entered an agreement to acquire Digital Audience, a data infrastructure company focused on identity and activation across digital channels.Dea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDLvTLN4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4539","BK4613","IE00BFMHRM44.USD","ZETA","ZETX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673640063","title":"Caribou Biosciences Plans Major Workforce Reduction, Halts CAR-T Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2673640063","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673640063?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:06","pubTimestamp":1791317160,"startTime":"0","endTime":"0","summary":"Caribou Biosciences plans major workforce reduction, halts CAR-T programsCaribou Biosciences launched a strategic review to maximize stockholder value, weighing options such as a merger or sale.Plans ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL5d8cp1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4112","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","LU2095319765.USD","CRBU","SG9999014039.USD","SG9999014021.USD","LU2210150020.SGD","BK4139","BCDF","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","LU0314104364.USD","LU2210149790.SGD","BK4539","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BKPKM429.USD","NDAQ","IE00BQXX3F31.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673063613","title":"1stDibs CEO Rosenblatt, CFO Etergino to Present at LD Micro Main Event Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2673063613","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673063613?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:05","pubTimestamp":1791317138,"startTime":"0","endTime":"0","summary":"1stDibs CEO Rosenblatt, CFO Etergino to present at LD Micro Main Event conference1stdibs will present at the LD Micro 20th Annual Main Event Conference in Los Angeles on Oct. 21 at 12:30 p.m. ET.CEO D","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL6qwtWG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4220","BK4122","BK4539","DIBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673063506","title":"Zeta Global to Acquire Digital Audience, Extending the Zeta Data Cloud Across the Digital Ecosystem","url":"https://stock-news.laohu8.com/highlight/detail?id=2673063506","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673063506?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:05","pubTimestamp":1791317101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA44WXD4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4613","BK4023","BK4539","ZETX","ZETA","IE00BFMHRM44.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673637063","title":"Caribou Biosciences to Evaluate Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2673637063","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673637063?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:05","pubTimestamp":1791317101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA5L4XV1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673506365","title":"Caribou Biosciences - Reports Cash and Securities of $113.80 Mln as of June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673506365","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673506365?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:05","pubTimestamp":1791317101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA5L4XV1:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673063658","title":"Caribou Biosciences - Plans Substantial Workforce Reduction Expected to be Mostly Complete in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673063658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673063658?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:05","pubTimestamp":1791317101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA5L4XV1:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CRBU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673063572","title":"Caribou Biosciences - to Discontinue Vispa-Cel and CB-011 CAR-T Cell Therapy Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2673063572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673063572?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:05","pubTimestamp":1791317101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA5L4XV1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673063508","title":"Caribou Biosciences - to Implement Workforce and Cost Reductions","url":"https://stock-news.laohu8.com/highlight/detail?id=2673063508","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673063508?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:05","pubTimestamp":1791317101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA5L4XV1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRBU","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":40,"pageCount":5,"totalSize":788,"code":"91000000","status":"200"}]}}